Section : News
Judes Poirier, PhD,C.Q, received the prestigious BIOQuébec 2010 Genesis Award in the Biotechnology of Tomorrow category.
Section : News
Transcranial Magnetic Stimulation—offering an alternative treatment for major depression
Section : News
The winner of the 2007 Douglas Cup for the best team at the Douglas Institute, the Moe Levin Centre is located in the CPC Pavilion, where it provides specialized care to patients suffering from cognitive disorders such as Alzheimer's disease. At the C
Section : News
On November 24, University of Montpellier I in France awarded the title of Doctor Honoris Causa to Judes Poirier, PhD, C.Q., professor and researcher in molecular neurobiology. This honorary title was conferred by the oldest faculty of medicine in the
Section : News
Did you know? The philanthropy of our employees is essential to the Douglas’ mission. Your gifts represent one third of all individual donations raised by the Foundation. As Douglas employees, you are part of the Douglas Family. Your
Section : News
The Foundation supports 33 researchers, nearly half of the 67 researchers working at the Douglas. In 2008–2009, members of the Research Centre published 215 scientific papers, book chapters and books documenting scientific breakthroughs and ther
Section : News
Imagine a world where research was no longer a priority … We would be prisoners of the past. People suffering from mental illness would most likely still be housed in asylums, ostracized and marginalized. Internationally renowned Douglas scient Your Support Produces a Wealth of Discoveries.
Section : News
425,000 Canadians suffer from memory problems. Do you remember your birthday? The day you turned 18? Your children’s name? Your first kiss? Your favorite dessert? The loss of memory is like losing your history, your past, your points
Section : News
Remi Quirion, PhD, new Executive Director of the International Collaborative Research Strategy for Alzheimer's Disease.
Section : News
The Douglas Institute is part of an international effort to investigate a new treatment A vaccine-based approach could be an effective therapy for people with mild or moderate forms of Alzheimer’s disease. The medication used for this therapy w